INR at Home Measurement by the LabPad ® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)
Conditions: Vitamine K Antagonist (VKA) Treatment; International Normalized Ratio (INR) Measure at Home Intervention: Device: LabPad® point-of-care Sponsors: Medicalps; AG2R La Mondiale; AVALUN; Icadom; ORIADE NOVIALE; SIL-LAB INNOVATIONS; TASDA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 7, 2019 Category: Research Source Type: clinical trials
Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters
Condition: Venous Thromboembolism Interventions: Drug: Rivaroxaban; Drug: Warfarin; Drug: Nadroparin Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University; Sir Run Run Shaw Hospital; Huadong Hospital; Shanghai Zhongshan Hospital; Shanghai 5th People's Hospital; Yantai Yuhuangding Hospital; Anhui Provincial Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 26, 2019 Category: Research Source Type: clinical trials
Long-term Outcome After Edoxaban Versus Vitamin K Antagonists for Acute VTE
Conditions: Venous Thromboembolic Disease; Post Thrombotic Syndrome; Chronic Thromboembolic Pulmonary Hypertension; Quality of Life Intervention: Other: Observation Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2019 Category: Research Source Type: clinical trials
